Biosimilars Forum lobbying group established; founding members are ACT, AMGN, B-I, CHRS, Merck-Serono, MRK, NVS, PFE/HSP, Samsung, and TEVA (but not BXLT, EPRS, MNTA, MYL, PFNX, and VRX):
x Nine products: Herceptin, Neulasta, Avastin, Humira, Enbrel, Lantus, Novolog, Humalog, one undisclosed.
z Each company received a distinct EU/CHMP approval for Remicade on 6/28/13; partnership includes seven (other) products: Rituxan, Herceptin, Enbrel, Erbitux, Synagis, Humira, Avastin.